Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A small literature suggests that pharmacotherapy may be useful in the prophylaxis of posttraumatic stress disorder in patients presenting with major trauma. There is relatively little data, however, on the use of selective serotonin reuptake inhibitors (SSRIs) in this context. METHODS: 24 week, double-blind placebo controlled study. 31 participants presenting immediately after trauma, and meeting diagnostic criteria for full or partial acute stress disorder were randomized to treatment with 10-20 mg of escitalopram or placebo daily for 24 weeks. 2 participants were excluded from the analysis due to early drop out, leaving 29 participants (escitalopram = 12, placebo = 17) for inclusion in an intent- to- treat analysis. Participants were followed up until 56 weeks, and assessed with the Clinician Administered PTSD Scale (CAPS). A mixed model repeated measures analysis of variance (RMANOVA) was undertaken to determine the efficacy of the intervention on the CAPS score. RESULTS: There was a significant reduction in CAPS score over the course of treatment (F(7, 142) = 41. 58, p < 0.001) in both the escitalopram and placebo groups, with a greater reduction in CAPS score in the placebo group F(7, 142) = 2.12, p = 0.045. There were improvements on all secondary measures, including the Clinical Global Impressions scale, and scales assessing depression, anxiety and disability. Only functional disability outcomes (F(7, 141) = 2.13, p = .04), were significantly different between treatment and placebo groups. In the sample as a whole, improvement in scores were maintained at the 52 week follow-up. Side effects were comparable between the groups. CONCLUSIONS: These data are consistent with other recent work indicating that the SSRIs may not be efficacious in the prevention of PTSD. Nevertheless, the small sample size and baseline differences between groups limit the explanatory power of the study. Although a consideration of the possibility of medication prophylaxis in PTSD remains important, both from conceptual and clinical perspectives, caution is needed with regards to the use of SSRIs until their efficacy can be proven. TRIAL REGISTRATION: Clinical Trials NCT00300313.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychological treatment of post-traumatic stress disorder (PTSD)
Bisson, J., & Andrew, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003388.pub3 · Cited by 545
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519 · cited 1×
“Furthermore, a systematic review of pharmacotherapy for PTSD [14] concluded that SSRIs are effective in treating PTSD in both the short and longer term.”
BackgroundSelf-citationDavidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470
Cited by
Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C. (2019) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180046 · Cited by 14
“Only two trials had a drop-out rate below 20% [33, 37].”
BackgroundResultInfluentialEarly interventions for the prevention of PTSD in adults: a systematic literature review
LINARES, I. M. P., CORCHS, F. D. F., CHAGAS, M. H. N., ZUARDI, A. W., MARTIN-SANTOS, R., & CRIPPA, J. A. S. (2017) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000109 · Cited by 13
Wang, X., Fan, Y., Li, G., & Li, H. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000350 · Cited by 4
Metadata
- Authors
- Suliman, S., Seedat, S., Pingo, J., Sutherland, T., Zohar, J., & Stein, D. J.
- Venue
- BMC Psychiatry
- Published
- 2015-02-19
- Volume
- 15
- Issue
- 1
- Pages
- 24-24
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W2131315861
- Cited by
- 38
- References
- 3
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12888-015-0391-3
- The paper
- Suliman, S., Seedat, S., Pingo, J., Sutherland, T., Zohar, J., & Stein, D. J. (2015). Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial. BMC Psychiatry. https://doi.org/10.1186/s12888-015-0391-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.